Borislava Grinblat

Statistics

Publications

Citations

559

H-Index

Active since

2004

Affiliations

Teva Pharmaceuticals (Israel)(Current)

Bar-Ilan University

Borislava Grinblat is an author at Teva Pharmaceuticals (Israel) specializing in molecular biology, cell biology, and bone marrow-derived mesenchymal stromal cells.

Publications per year

2004–2011

Publications

Markers Distinguishing Mesenchymal Stem Cells from Fibroblasts Are Downregulated with Passaging

Svetlana Halfon, Natalie Abramov, Borislava Grinblat et al. · Stem Cells and Development · 2010 · 326 citations

Life Sciences, Cell Biology, Stem Cell Biology +13

Evaluation of Bone Marrow-Derived Mesenchymal Stem Cells After Cryopreservation and Hypothermic Storage in Clinically Safe Medium

Irene Ginis, Borislava Grinblat, Mitchell Shirvan · Tissue Engineering Part C Methods · 2011 · 114 citations

Engineering, Biomedical Engineering, Cell Biology +14

Increased Expression of the<i>hPim-2</i>Gene In Human Chronic lymphocytic Leukemia and Non-Hodgkin Lymphoma

Amos Cohen, Borislava Grinblat, Hanna Bessler et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2004 · 107 citations

Medicine, Molecular Biology, Oncology +6

Proteasomal degradation regulates expression of porphobilinogen deaminase (PBGD) mutants of acute intermittent porphyria

Nurit Grünberg-Etkovitz, Lior Greenbaum, Borislava Grinblat et al. · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 2006 · 12 citations

Life Sciences, Biochemistry, Molecular Biology +14

1–4 of 4